The New York Regional Diabetes Research Center (NYR-DRC) comprises a vibrant, comprehensive, well-funded, and highly productive program that provides the foundation for high-quality and cutting-edge research in diabetes and related studies in obesity, metabolism, and endocrinology.
Biomedical Cores
Animal Physiology Core
The Human Islet & Adenovirus Core (HIAC)
Stable Isotope & Metabolomics Core
Translational Research Core
Immuno-Technology Core (NEW)
Human Therapeutic Organoid Core (located at Weill Cornell Medicine)
Recent Publications
-
Novel Insights into the Pathogenic Impact of Diabetes on the Gastrointestinal Tract
-
Menopausal hormone therapy and subclinical cardiovascular disease in women with and without HIV
-
Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF study
-
Butyrate acts through HDAC inhibition to enhance aryl hydrocarbon receptor activation by gut microbiota-derived ligands
-
From resveratrol to ISIDE11: how to activate SIRT1 and improve endothelial function? New therapeutic insights for methylenetetrahydrofolate reductase deficiency
Upcoming Events
Video could not be played
In person
Diabetes Center Conference
Friday, September 18 from 09:00am - 10:00am
Video could not be played
In person
Diabetes Center Conference
Friday, September 25 from 09:00am - 10:00am